| |
|
|
Drug name
|
Condition |
Division |
| Helixate® FS (antihemophilic factor [recombinant]) |
Hemophilia/Bleeding Disorders |
Hemophilia Health Services |
| Hemofil® M (antihemophilic factor [human]) |
Hemophilia/Bleeding Disorders |
Hemophilia Health Services |
| Herceptin® (trastuzumab) |
Oncology |
Accredo Nova Factor |
| H.P. Acthar Gel |
Multiple Sclerosis |
Accredo Nova Factor |
| Humate-P® (antihemophilic factor/von Willebrand factor complex [human]) |
Hemophilia/Bleeding Disorders |
Hemophilia Health Services |
| Humatrope® (somatropin [rDNA origin]) |
Growth Disorders |
Accredo Nova Factor |
| Humira® (adalimumab) |
Rheumatoid Arthritis |
Accredo Nova Factor |
| Hyalgan® (sodium hyaluronate) |
Osteo-arthritis |
Accredo Nova Factor |
| Hyate:C® (antihemophilic factor [porcine]) |
Hemophilia/Bleeding Disorders |
Hemophilia Health Services |
| HyperRho® S/D (Rho[D] immune globulin [human]) |
Immune Deficiency |
Accredo Therapeutics |